Flagship Pioneering
Asia Leaders
Noubar Afeyan’s Venture Factory Faces the Test That Matters: Translation
Flagship Pioneering enters 2026 with $14 billion under direction and fresh companies spanning modified DNA, AI and agriculture. The harder challenge is converting breadth into repeatable clinical and commercial evidence.
Asia Leaders
Noubar Afeyan Is Exporting Flagship’s Venture Factory to Sovereign Health Systems
Flagship Pioneering is extending its venture-creation model through Saudi, Singaporean and British institutions. Noubar Afeyan must convert privileged data and regulatory access into investable companies without compromising privacy, ownership or speed.